Amy L. Parkhill, Ph.D.
Affiliations: | 2003 | University of Rochester, Rochester, NY |
Area:
PharmacologyGoogle:
"Amy Parkhill"Mean distance: (not calculated yet)
Parents
Sign in to add mentorJean M. Bidlack | grad student | 2003 | Rochester | |
(Investigation of the possible cellular mechanisms of delta-opioid receptor subtype-pharmacology.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bidlack JM, Khimich M, Parkhill AL, et al. (2006) Opioid receptors and signaling on cells from the immune system. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 1: 260-9 |
Wentland MP, VanAlstine M, Kucejko R, et al. (2006) Redefining the structure-activity relationships of 2,6-methano-3- benzazocines. 4. Opioid receptor binding properties of 8-[n-(4′-phenyl)- phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine Journal of Medicinal Chemistry. 49: 5635-5639 |
Parkhill AL, Bidlack JM. (2006) Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50,488 in a mouse monocyte-like cell line. International Immunopharmacology. 6: 1013-9 |
Bidlack JM, Parkhill AL. (2004) Assay of G protein-coupled receptor activation of G proteins in native cell membranes using [35S]GTP gamma S binding. Methods in Molecular Biology (Clifton, N.J.). 237: 135-43 |
Parkhill AL, Bidlack JM. (2002) Several delta-opioid receptor ligands display no subtype selectivity to the human delta-opioid receptor. European Journal of Pharmacology. 451: 257-64 |